본문 바로가기
KERD
논문KCI 등재

The Role of Gut Microbiota and Genetic Susceptibility in the Pathogenesis of Pancreatitis

2

조회

0

다운로드

0

인용

0

참고문헌

키워드

초록

Pancreatitis is one of the most common inflammatory diseases of the pancreas caused by autodigestion induced by excessive premature protease activation. However, recognition of novel pathophysiological mechanisms remains a still challenge. Both genetic and environmental factors contribute to the pathogenesis of pancreatitis, and the gut microbiota is a potential source of an environmental effect. In recent years, several new frontiers in gut microbiota and genetic risk assessment research have emerged and improved the understanding of the disease. These investigations showed that the disease progression of pancreatitis could be regulated by the gut microbiome, either through a translocation influence or in a host immune response manner. Meanwhile, the onset of the disease is also associated with the heritage of a pathogenic mutation, and the disease progression could be modified by genetic risk factors. In this review, we focused on the recent advances in the role of gut microbiota in the pathogenesis of pancreatitis, and the genetic susceptibility in pancreatitis.

Abstract

Pancreatitis is one of the most common inflammatory diseases of the pancreas caused by autodigestion induced by excessive premature protease activation. However, recognition of novel pathophysiological mechanisms remains a still challenge. Both genetic and environmental factors contribute to the pathogenesis of pancreatitis, and the gut microbiota is a potential source of an environmental effect. In recent years, several new frontiers in gut microbiota and genetic risk assessment research have emerged and improved the understanding of the disease. These investigations showed that the disease progression of pancreatitis could be regulated by the gut microbiome, either through a translocation influence or in a host immune response manner. Meanwhile, the onset of the disease is also associated with the heritage of a pathogenic mutation, and the disease progression could be modified by genetic risk factors. In this review, we focused on the recent advances in the role of gut microbiota in the pathogenesis of pancreatitis, and the genetic susceptibility in pancreatitis.

참고문헌 (100)

  1. Peery AF, "Burden and cost of gastrointestinal, liver, and pancreatic diseases in the United States : update 2018", Gastroenterology, 156, pp.254~272 (2019)
  2. Petrov MS, "Global epidemiology and holistic prevention of pancreatitis", Nat Rev Gastroenterol Hepatol, 16, pp.175~184 (2019)
  3. Lugea A, "Human pancreatic acinar cells : proteomic characterization, physiologic responses, and organellar disorders in ex vivo pancreatitis", Am J Pathol, 187, pp.2726~2743 (2017)
  4. Gukovskaya AS, "New insights into the pathways initiating and driving pancreatitis", Curr Opin Gastroenterol, 32, pp.429~435 (2016)
  5. Banks PA, "Classification of acute pancreatitis : 2012. Revision of the Atlanta classification and definitions by international consensus", Gut, 62, pp.102~111 (2013)
  6. Lee PJ, "New insights into acute pancreatitis", Nat Rev Gastroenterol Hepatol, 16, pp.479~496 (2019)
  7. Yadav D, "Pancreatitis : prevalence and risk factors among male veterans in a detoxification program", Pancreas, 34, pp.390~398 (2007)
  8. Whitcomb DC, "Genetic risk factors for pancreatic disorders", Gastroenterology, 144, pp.1292~1302 (2013)
  9. BrestoffJR, "Commensal bacteria at the interface of host metabolism and the immune system", Nat Immunol, 14, pp.676~684 (2013)
  10. Thomas RM, "Intestinal microbiota enhances pancreatic carcinogenesis in preclinical models", Carcinogenesis, 39, pp.1068~1078 (2018)
  11. Pushalkar S, "The pancreatic cancer microbiome promotes oncogenesis by induction of innate and adaptive immune suppression", Cancer Discov, 8, pp.403~416 (2018)
  12. Sun J, "Pancreatic β-cells limit autoimmune diabetes via an immunoregulatory antimicrobial peptide expressed under the influence of the gut microbiota", Immunity, 43, pp.304~317 (2015)
  13. Ahuja M, "Orai1-mediated antimicrobial secretion from pancreatic acini shapes the gut microbiome and regulates gut innate immunity", Cell Metab, 25, pp.635~646 (2017)
  14. Geller LT, "Potential role of intratumor bacteria in mediating tumor resistance to the chemotherapeutic drug gemcitabine", Science, 357, pp.1156~1160 (2017)
  15. Aghdassi AA, "Genetic susceptibility factors for alcohol-induced chronic pancreatitis", Pancreatology, 15(4 Suppl), pp.S23~S31 (2015)
  16. Solomon S, "Genetics of pancreatitis : an update for clinicians and genetic counselors", Curr Gastroenterol Rep, 14, pp.112~117 (2012)
  17. Chandak GR, "Absence of PRSS1mutations and association of SPINK1 trypsin inhibitor mutations in hereditary and non-hereditary chronic pancreatitis", Gut, 53, pp.723~728 (2004)
  18. Lerch MM, "Models of acute and chronic pancreatitis", Gastroenterology, 144, pp.1180~1193 (2013)
  19. Zhang XM, "Intestinal microbial community differs between acute pancreatitis patients and healthy volunteers", Biomed Environ Sci, 31, pp.81~86 (2018)
  20. Li Q, "Bacteremia in patients with acute pancreatitis as revealed by 16S ribosomal RNA gene-based techniques*", Crit Care Med, 41, pp.1938~1950 (2013)
  21. Yu S, "Identification of dysfunctional gut microbiota through rectal swab in patients with different severity of acute pancreatitis", Dig Dis Sci, 65, pp.3223~3237 (2020)
  22. Hu X, "Variations in gut microbiome are associated with prognosis of hypertriglyceridemia-associated acute pancreatitis", Biomolecules, 11, pp.695~ (2021)
  23. Zhu Y, "Gut microbiota dysbiosis worsens the severity of acute pancreatitis in patients and mice", J Gastroenterol, 54, pp.347~358 (2019)
  24. Besselink MG, "Probiotic prophylaxis in predicted severe acute pancreatitis : a randomised, double-blind, placebo-controlled trial", Lancet, 371, pp.651~659 (2008)
  25. Oláh A, "Synbiotic control of inflammation and infection in severe acute pancreatitis : a prospective, randomized, double blind study", Hepatogastroenterology, 54, pp.590~594 (2007)
  26. Cui LH, "The effects of early enteral nutrition with addition of probiotics on the prognosis of patients suffering from severe acute pancreatitis", Zhonghua Wei Zhong Bing Ji Jiu Yi Xue, 25, pp.224~228 (2013)
  27. Plaudis H, "Early low volume oral synbiotic", prebiotic supplemented enteral stimulation of the gut in patients with severe acute pancreatitis : a prospective feasibility study, 2012, pp.112, 131~138
  28. Yu C, "An updated systematic review with meta-analysis : efficacy of prebiotic, probiotic, and synbiotic treatment of patients with severe acute pancreatitis", Pancreas, 50, pp.160~166 (2021)
  29. Lei Y, "Parabacteroides produces acetate to alleviate heparanase-exacerbated acute pancreatitis through reducing neutrophil infiltration", Microbiome, 9, pp.115~ (2021)
  30. Bures J, "Small intestinal bacterial overgrowth syndrome", World J Gastroenterol, 16, pp.2978~2990 (2010)
  31. Memba R, "The potential role of gut microbiota in pancreatic disease : a systematic review", Pancreatology, 17, pp.867~874 (2017)
  32. Jandhyala SM, "Altered intestinal microbiota in patients with chronic pancreatitis : implications in diabetes and metabolic abnormalities", Sci Rep, 7, pp.43640~ (2017)
  33. Gorovits ES, "Complex evaluation of intestine microbiocenosis condition in patients with chronic pancreatitis", Zh Mikrobiol Epidemiol Immunobiol, (4), pp.73~76 (2013)
  34. Savitskaia KI, "Evaluation of microecology of colonic contents in patients with chronic pancreatitis", Vestn Ross Akad Med Nauk, (4), pp.20~23 (2002)
  35. Leal-Lopes C, "Roles of commensal microbiota in pancreas homeostasis and pancreatic pathologies", J Diabetes Res, 2015, pp.284680~ (2015)
  36. Hamada S, "Differences in gut microbiota profiles between autoimmune pancreatitis and chronic pancreatitis", Tohoku J Exp Med, 244, pp.113~117 (2018)
  37. Shimosegawa T, "International consensus diagnostic criteria for autoimmune pancreatitis : guidelines of the International Association of Pancreatology", Pancreas, 40, pp.352~358 (2011)
  38. Yanagisawa N, "Identification of commensal flora-associated antigen as a pathogenetic factor of autoimmune pancreatitis", Pancreatology, 14, pp.100~106 (2014)
  39. Akshintala VS, "The gut microbiome in pancreatic disease", Clin Gastroenterol Hepatol, 17, pp.290~295 (2019)
  40. Wu LM, "Meta-analysis of gut barrier dysfunction in patients with acute pancreatitis", Br J Surg, 101, pp.1644~1656 (2014)
  41. Thomas RM, "Microbiota in pancreatic health and disease : the next frontier in microbiome research", Nat Rev Gastroenterol Hepatol, 17, pp.53~64 (2020)
  42. O'Boyle CJ, "Microbiology of bacterial translocation in humans", Gut, 42, pp.29~35 (1998)
  43. MacFie J, "Gut origin of sepsis : a prospective study investigating associations between bacterial translocation, gastric microflora, and septic morbidity", Gut, 45, pp.223~228 (1999)
  44. Sendler M, "Cathepsin B-mediated activation of trypsinogen in endocytosing macrophages increases severity of pancreatitis in mice", Gastroenterology, 154, pp.704~718 (2018)
  45. Antonucci L, "Basal autophagy maintains pancreatic acinar cell homeostasis and protein synthesis and prevents ER stress", Proc Natl Acad Sci U S A, 112, pp.E6166~E6174 (2015)
  46. Chu H, "Innate immune recognition of the microbiota promotes host-microbial symbiosis", Nat Immunol, 14, pp.668~675 (2013)
  47. Brown RL, "The regulation of host defences to infection by the microbiota", Immunology, 150, pp.1~6 (2017)
  48. Rosenstiel P, "Evolution and function of innate immune receptors : insights from marine invertebrates", J Innate Immun, 1, pp.291~300 (2009)
  49. Watanabe T, "Nucleotidebinding oligomerization domain 1 acts in concert with the cholecystokinin receptor agonist, cerulein, to induce IL-33-dependent chronic pancreatitis", Mucosal Immunol, 9, pp.1234~1249 (2016)
  50. Tsuji Y, "Sensing of commensal organisms by the intracellular sensor NOD1 mediates experimental pancreatitis", Immunity, 37, pp.326~338 (2012)
  51. Medveczky P, "Proteolytic activation of human pancreatitis-associated protein is required for peptidoglycan binding and bacterial aggregation", Biochem J, 420, pp.335~343 (2009)
  52. Doyle CJ, "The proteome of normal pancreatic juice", Pancreas, 41, pp.186~194 (2012)
  53. Shelton C, "GeneReviews®", University of Washington
  54. Whitcomb DC, "Hereditary pancreatitis is caused by a mutation in the cationic trypsinogen gene", Nat Genet, 14, pp.141~145 (1996)
  55. Bombieri C, "Recommendations for the classification of diseases as CFTR-related disorders", J Cyst Fibros, 10(Suppl 2), pp.S86~S102 (2011)
  56. Amann ST, "Expression and penetrance of the hereditary pancreatitis phenotype in monozygotic twins", Gut, 48, pp.542~547 (2001)
  57. Joergensen MT, "Genetic, epidemiological, and clinical aspects of hereditary pancreatitis: a populationbased cohort study in Denmark", Am J Gastroenterol, 105, pp.1876~1883 (2010)
  58. Gorry MC, "Mutations in the cationic trypsinogen gene are associated with recurrent acute and chronic pancreatitis", Gastroenterology, 113, pp.1063~1068 (1997)
  59. Howes N, "Clinical and genetic characteristics of hereditary pancreatitis in Europe", Clin Gastroenterol Hepatol, 2, pp.252~261 (2004)
  60. Rebours V, "The natural history of hereditary pancreatitis : a national series", Gut, 58, pp.97~103 (2009)
  61. Witt H, "Chronic pancreatitis : challenges and advances in pathogenesis, genetics, diagnosis, and therapy", Gastroenterology, 132, pp.1557~1573 (2007)
  62. Chen JM, "Chronic pancreatitis : genetics and pathogenesis", Annu Rev Genomics Hum Genet, 10, pp.63~87 (2009)
  63. Whitcomb DC, "Genetic aspects of pancreatitis", Annu Rev Med, 61, pp.413~424 (2010)
  64. LaRusch J, "Genetics of pancreatitis", Curr Opin Gastroenterol, 27, pp.467~474 (2011)
  65. Chen JM, "Genetics and pathogenesis of chronic pancreatitis : the 2012 update", Clin Res Hepatol Gastroenterol, 36, pp.334~340 (2012)
  66. Whitcomb DC, "Common genetic variants in the CLDN2 and PRSS1-PRSS2 loci alter risk for alcohol-related and sporadic pancreatitis", Nat Genet, 44, pp.1349~1354 (2012)
  67. Whitcomb DC, "Mechanisms of disease : advances in understanding the mechanisms leading to chronic pancreatitis", Nat Clin Pract Gastroenterol Hepatol, 1, pp.46~52 (2004)
  68. Zator Z, "Insights into the genetic risk factors for the development of pancreatic disease", Therap Adv Gastroenterol, 10, pp.323~336 (2017)
  69. Hegyi E, "Genetic risk in chronic pancreatitis : the trypsin-dependent pathway", Dig Dis Sci, 62, pp.1692~1701 (2017)
  70. Witt H, "A degradation-sensitive anionic trypsinogen(PRSS2)variant protects against chronic pancreatitis", Nat Genet, 38, pp.668~673 (2006)
  71. Witt H, "Mutations in the gene encoding the serine protease inhibitor, Kazal type 1 are associated with chronic pancreatitis", Nat Genet, 25, pp.213~216 (2000)
  72. Aoun E, "Pathways to injury in chronic pancreatitis : decoding the role of the high-risk SPINK1 N34S haplotype using meta-analysis", PLoS One, 3, pp.e2003~ (2008)
  73. Midha S, "Idiopathic chronic pancreatitis in India : phenotypic characterisation and strong genetic susceptibility due to SPINK1 and CFTR gene mutations", Gut, 59, pp.800~807 (2010)
  74. Rosendahl J, "CFTR, SPINK1, CTRC and PRSS1 variants in chronic pancreatitis : is the role of mutated CFTR overestimated", Gut, 62, pp.582~592 (2013)
  75. Schneider A, "Combined bicarbonate conductance-impairing variants in CFTR and SPINK1variants are associated with chronic pancreatitis in patients without cystic fibrosis", Gastroenterology, 140, pp.162~171 (2011)
  76. Weiss FU, "Complete cystic fibrosis transmembrane conductance regulator gene sequencing in patients with idiopathic chronic pancreatitis and controls", Gut, 54, pp.1456~1460 (2005)
  77. Choudari CP, "Risk of pancreatitis with mutation of the cystic fibrosis gene", Am J Gastroenterol, 99, pp.1358~1363 (2004)
  78. Castellani C, "Increased prevalence of mutations of the cystic fibrosis gene in idiopathic chronic and recurrent pancreatitis", Am J Gastroenterol, 94, pp.1993~1995 (1999)
  79. Hasan A, "The role of genetics in pancreatitis", Gastrointest Endosc Clin N Am, 28, pp.587~603 (2018)
  80. Keller J, "Idiopathic chronic pancreatitis", Best Pract Res Clin Gastroenterol, 22, pp.105~113 (2008)
  81. KleeffJ, "Chronic pancreatitis", Nat Rev Dis Primers, 3, pp.17060~ (2017)
  82. Schneider A, "Limited contribution of the SPINK1N34S mutation to the risk and severity of alcoholic chronic pancreatitis : a report from the United States", Dig Dis Sci, 48, pp.1110~1115 (2003)
  83. Yadav D, "Alcohol consumption, cigarette smoking, and the risk of recurrent acute and chronic pancreatitis", Arch Intern Med, 169, pp.1035~1045 (2009)
  84. Yadav D, "The role of alcohol and smoking in pancreatitis", Nat Rev Gastroenterol Hepatol, 7, pp.131~145 (2010)
  85. Derikx MH, "Polymorphisms at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with alcoholic and non-alcoholic chronic pancreatitis in a European replication study", Gut, 64, pp.1426~1433 (2015)
  86. Masamune A, "Common variants at PRSS1-PRSS2 and CLDN2-MORC4 loci associate with chronic pancreatitis in Japan", Gut, 64, pp.1345~1346 (2015)
  87. Scherer J, "Issues in hypertriglyceridemic pancreatitis : an update", J Clin Gastroenterol, 48, pp.195~203 (2014)
  88. Johansen CT, "Genetic bases of hypertriglyceridemic phenotypes", Curr Opin Lipidol, 22, pp.247~253 (2011)
  89. Alves-Bezerra M, "Triglyceride metabolism in the liver", Compr Physiol, 8, pp.1~8 (2017)
  90. Chang YT, "Association of cystic fibrosis transmembrane conductance regulator(CFTR)mutation", variant, Clin Chem, pp.2008, 54[DOI]
  91. Juliani FC, "Predisposing factors to acute pancreatitis in patients with severe hypertriglyceridemia", Eur Heart J, 41(Suppl 2), pp.ehaa946.29~ (2020)
  92. Kerem B, "Identification of the cystic fibrosis gene : genetic analysis", Science, 245, pp.1073~1080 (1989)
  93. Rosendahl J, "Chymotrypsin C(CTRC)variants that diminish activity or secretion are associated with chronic pancreatitis", Nat Genet, 40, pp.78~82 (2008)
  94. Felderbauer P, "A novel mutation of the calcium sensing receptor gene is associated with chronic pancreatitis in a family with heterozygous SPINK1mutations", BMC Gastroenterol, 3, pp.34~ (2003)
  95. Wang J, "Of genes and microbes : solving the intricacies in host genomes", Protein Cell, 9, pp.446~461 (2018)
  96. Rothhammer V, "Type I interferons and microbial metabolites of tryptophan modulate astrocyte activity and central nervous system inflammation via the aryl hydrocarbon receptor", Nat Med, 22, pp.586~597 (2016)
  97. Jones EA, "Copy number variation of the beta defensin gene cluster on chromosome 8p influences the bacterial microbiota within the nasopharynx of otitis-prone children", PLoS One, 9, pp.e98269~ (2014)
  98. Blekhman R, "Host genetic variation impacts microbiome composition across human body sites", Genome Biol, 16, pp.191~ (2015)
  99. Russell JT, "Genetic risk for autoimmunity is associated with distinct changes in the human gut microbiome", Nat Commun, 10, pp.3621~ (2019)
  100. Wang W, "Disordered gut microbiota in children who have chronic pancreatitis and different functional gene mutations", Clin Transl Gastroenterol, 11, pp.e00150~ (2020)

관련 논문AI추천

이 간행물의 다른 논문 (17건)